Taysha Gene Therapies, Inc.
4 clinical trials · Sponsor
◉ Watch Taysha Gene Therapies, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome (NCT07480564) | Taysha Gene Therapies, Inc. | 2026-05-08 |
| Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study) (NCT06152237) | Taysha Gene Therapies, Inc. | 2023-12-12 |
| A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study) (NCT05606614) | Taysha Gene Therapies, Inc. | 2023-03-06 |
| A Study of the Natural Course of SURF1 Deficiency (NCT05277363) | Taysha Gene Therapies, Inc. | 2022-05-04 |
Track Taysha Gene Therapies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.